XBI icon

SPDR S&P Biotech ETF

660 hedge funds and large institutions have $9.04B invested in SPDR S&P Biotech ETF in 2021 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 247 increasing their positions, 178 reducing their positions, and 59 closing their positions.

Holders
660
Holders Change
+19
Holders Change %
+2.96%
% of All Funds
11.52%
Holding in Top 10
17
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-15%
% of All Funds
0.3%
New
81
Increased
247
Reduced
178
Closed
59
Calls
$1.39B
Puts
$2.37B
Net Calls
-$978M
Net Calls Change
+$600M
Name Market Value Shares Shares
Change
Shares
Change %
GPCM
726
Granite Point Capital Management
Massachusetts
EP
727
Eversept Partners
New York
Alkeon Capital Management
728
Alkeon Capital Management
New York
BCPEMI
729
Bain Capital Public Equity Management II
Massachusetts
OSAM
730
O'Shaughnessy Asset Management
Connecticut
Public Sector Pension Investment Board (PSP Investments)
731
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
ACM
732
Atika Capital Management
New York
PVI
733
Pura Vida Investments
New York
BMCM
734
Black Maple Capital Management
Wisconsin
PHS
735
PFM Health Sciences
California
LCM
736
Laurion Capital Management
New York
Twin Tree Management
737
Twin Tree Management
Texas
NCM
738
Nantahala Capital Management
Connecticut
SCM
739
Silverarc Capital Management
Massachusetts
DIG
740
DeepCurrents Investment Group
New York
HNB
741
Huntington National Bank
Ohio
Walleye Trading
742
Walleye Trading
New York
AG
743
Artal Group
Luxembourg
Point72 Asset Management
744
Point72 Asset Management
Connecticut
CIM
745
Cowen Investment Management
New York
Holocene Advisors
746
Holocene Advisors
New York
SVI
747
Strategic Vision Investment
Hong Kong
CAM
748
CenterStar Asset Management
Illinois
MWNA
749
Marshall Wace North America
New York
DLPIC
750
Davide Leone & Partners Investment Company
United Kingdom